ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TYRU Tyratech (DI)

3.00
0.00 (0.00%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tyratech (DI) LSE:TYRU London Ordinary Share COM SHS USD0.001 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.00 2.80 3.20 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Tyratech (DI) Share Discussion Threads

Showing 976 to 998 of 3700 messages
Chat Pages: Latest  40  39  38  37  36  35  34  33  32  31  30  29  Older
DateSubjectAuthorDiscuss
16/3/2016
21:06
"Michaels" - please don't take the bait from this sad, lonely loser.
chinese investor
16/3/2016
20:59
Not a particularly good performance by this share really, considering all the ramping from the lunatic thread host.
professor pettigrew
16/3/2016
13:42
Thanks for that mudbath, it seems we may have seen the last of dilutive placings thanks to Vamousse.
michaelsadvfn
16/3/2016
13:02
10:50 16 Mar 2016


The firm has launched a new line of animal health biocide products branded 'PureScience', which will initially be aimed at poultry producers and be distributed in the USA
TyraTech Inc (LON:TYR, LON:TYRU) is undervalued and has a sizeable opportunity in the animal health market, says house broker Whitman Howard, which rates shares a 'buy'.

The firm has developed nature-derived insect and parasite control products and its flagship offering currently is the Vamousse headlice treatment, which has gained significant traction.

The anti-lice remedy and preventative shampoo has found its way into mainstream US retailers - notably Wal-Mart - and is making progress within the drug stores and in the UK market, said analyst Chris Wickham.

But earlier this year, TyraTech unveiled the launch a new line of animal health biocide products branded 'PureScience', which will initially be aimed at poultry producers and be distributed in the USA.

The range currently includes three formulations to control adult flies, immature flies and mites in industrial poultry production though Tyratech eventually expects to expand the range to cattle and pigs.

"TyraTech’s animal health opportunity is sizeable and probably not appreciated fully by the market," said the analyst, adding that animal health and agribusiness was a preferred growth “hot spot” within the broker's overall coverage of fast moving consumer goods (FMCG) stocks.

"There is a clear case for sustained growth in both the companion and production animal markets.

"The latter should be driven by higher consumer protein consumption. Avoidance of parasites infestation is important as, in our view, TyraTech’s products should succeed in aiding farms’ output and profitability."

The broker also applauds the group's business model, which outsources manufacturing and sales, so is structured to maximise flexibility and ensures scalability when launching new products and entering new geographies.

From 2016, the company will be able to finance expansion internally with sales and, ultimately, profit growth benefits accruing directly to shareholders, it also notes.

"TyraTech operates in the highly prized area of consumer health, in addition to having a substantial opportunity with animals."

Wickham argues this 'elegant combination' is not borne out in the group's current valuation and bases its potentially conservative 11p price target (current price: 3p) on 4.5 times' the average of 2016 and 2017 net sales.

mudbath
16/3/2016
09:58
Useful link...will put in the header...



...just key in your email address and you'll have access to any of the reports.

The latest from December 2015...



Interesting read, $7.7m expected revenue for 2015 + new 2017 estimates.

michaelsadvfn
14/3/2016
22:03
Another post BRINMING with info.Like most posters here I'm just wondering when your vitriolic rhetoric is going to be back by anything of substance.Your view appears to amount to little more than if a stock hasn't gone up in the past then it is very unlikely to go up in the future. A view with all the empirical merit of a wet f@rt.I have no idea how the market will react to the results in April, nor have I claimed to know. Yet apparently you do. Hope that isn't a very large hole you're digging there.
wigwammer
14/3/2016
18:41
When you are in a hole, stop digging. utter garbage.
corrientes
14/3/2016
17:40
"wigwammer if there was a competition to see who could convince people that black was white, you'd easily make the top quartile"Yes, the concept that a stock gets cheaper as the market cap falls is overwhelmingly complex.Bless.
wigwammer
14/3/2016
16:41
Vamousse on offer today at Superdrug with £5 off.
No stock though and the manager told me that they had sold out.
Imo there is nothing to read into the product being discounted for that is the nature of the Superdrug sales model with good reductions applying to a revolving range of products for limited periods.

mudbath
14/3/2016
15:34
I did some further market research! The Boots in my local market town now has 3 packs of Vamousse and no shampoo so they have sold at least one of those ;0)! There were more packs of all the other brands for what it is worth. Across the road at Lloyds they also had 3 packs. They previously had not any Vamousse at all when I went in there. So definitive evidence of wider distribution.

I agree that it is good that we have had this opportunity to buy in cheaply because of the overhang and because apparently the market has missed it! As I keep on saying the Vamousse brand alone must be worth more than the market cap to any larger company which has the resources to market it more thoroughly. Of course that is the limitation of a small company like TYR but I think they are doing a relatively good job.

GLA

Nobby

nobbygnome
14/3/2016
15:06
Why have a go at all ?

Enjoy the story,which ever way it might pan out.
I cannot see that there has been any ramping of TYRU; purely expressions of optimism from committed term investors.

mudbath
14/3/2016
13:49
wigwammer if there was a competition to see who could convince people that black was white, you'd easily make the top quartile.Mind you you'd be good for morale in
a sinking ship without any lifeboats.

Let's wait on the results ; then you can have a go, or vice versa.

corrientes
14/3/2016
12:22
A somewhat meaningless comment corrientes, if I may say so.I'm very pleased it has "passed the market by".
wigwammer
14/3/2016
10:55
Well its certainly passed the market by.
corrientes
14/3/2016
10:55
Well its certainly passed the market by.
corrientes
14/3/2016
09:35
corrientes,

Their achievements over the past 18 months appear to have passed you by.

Just saying like.

michaelsadvfn
14/3/2016
09:33
Wiggy,"I hear what you guys say" you are so right, just look at post 413, almost word for word from a previous punt that you know of.
A chairman holding lots of stock and someone dreaming of a £100 million+ company is not a recommendation (BEWARE).
Watch out for I have bought 50K or 100K, there is a pattern.

willib2
14/3/2016
09:24
"I hear what you guys say, but a decline of 80% plus, even more if you go back far enough, is not exactly encouraging".It is precisely the decline in price and market cap, combined with growing sales and shrinking losses, that lead me to think this has potential.Tyru may sink or swim - but at this stage there appears to be evidence to suggest the underlying story is making decent progress.
wigwammer
14/3/2016
08:54
The chairman in particular holds a lot of stock so they are incentivised to get the share price up. Jactel was quoted as saying he wanted to build a £100 million+ company. I don't think that issuing loads more paper is likely to work to get there easily so the price will have to go up to reach that goal!

Nobby

nobbygnome
14/3/2016
08:49
I hear what you guys say, but a decline of 80% plus, even more if you go back far enough, is not exactly encouraging in my books, nor to most other potential investors I suspect.

Odds on are that management will report more of the same again, and so the blinkers will remain firmly fixed. I really hope I am proved wrong.

corrientes
14/3/2016
08:18
"implying the shares are trading on a forward basis at around 0.7x sales"I like the stock, but thats pretty sloppy research.
wigwammer
14/3/2016
07:33
Thanks Michael, I hadn't seen that broker's report. The part about rapid growth and reordering us the most encouraging part.

The only thing holding the price back is the overhang from L&G selling out. If corrientes fails to realise that then it is his loss. When the selling is done this will suddenly pop to close to 5p IMHO. Of course none of us know when that will be but it can't be far away. As always patience is a virtue.......

Nobby

nobbygnome
14/3/2016
06:43
Published just over 3 weeks ago...



Multiple tier 1 customers re-ordering...

existing cash and the growing revenues should comfortably be enough to see it to profitability...

michaelsadvfn
Chat Pages: Latest  40  39  38  37  36  35  34  33  32  31  30  29  Older

Your Recent History

Delayed Upgrade Clock